Detecting Metastatic Prostate Cancer Risk in Black Men
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read MorePosted by Andy Lundin | Aug 15, 2023 | Prostate |
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read MorePosted by Andy Lundin | Aug 8, 2023 | Prostate |
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read MorePosted by Andy Lundin | Aug 2, 2023 | Sepsis |
Cytovale announced the U.S. commercial launch of the IntelliSep sepsis test following FDA 510(k) clearance in December 2022.
Read MorePosted by Andy Lundin | Aug 1, 2023 | Prostate |
A new study demonstrated Decipher Prostate Genomic Classifier’s ability to guide personalized treatment for men with prostate cancer.
Read MorePosted by Andy Lundin | Jul 28, 2023 | Cancer |
A team of scientists developed a label-free SERS-Artificial intelligence method for cancer screening (SERS-AICS).
Read More